WallStreetZenWallStreetZen

NASDAQ: NBTX
Nanobiotix Sa Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their NBTX stock forecasts and price targets.

Forecast return on equity

Is NBTX forecast to generate an efficient return?

Company
-44.6%
Industry
94.72%
Market
-61.89%
NBTX's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is NBTX forecast to generate an efficient return on assets?

Company
68.07%
Industry
36.87%
NBTX is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

NBTX earnings per share forecast

What is NBTX's earnings per share in the next 3 years based on estimates from 2 analysts?

Avg 1 year Forecast
-$0.45
Avg 2 year Forecast
$1.24
Avg 3 year Forecast
-$0.23

NBTX revenue forecast

What is NBTX's revenue in the next 3 years based on estimates from 2 analysts?

Avg 1 year Forecast
$49.1M+311.19%
Avg 2 year Forecast
$191.9M+1,506.16%
Avg 3 year Forecast
$111.0M+828.57%
NBTX's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

NBTX revenue growth forecast

How is NBTX forecast to perform vs Biotechnology companies and vs the US market?

Company
144.61%
Industry
87.42%
Market
11.67%
NBTX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
NBTX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

NBTX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
NBTX$30.31N/AN/A
AUPH$11.10$13.00+17.12%Buy
BCRX$7.04$17.13+143.25%Strong Buy
CDTX$116.15$128.00+10.20%Strong Buy
HRMY$26.36$46.29+75.59%Strong Buy
View Top Biotech Stocks

Nanobiotix Sa Stock Forecast FAQ

What is NBTX's earnings growth forecast for 2025-2027?

(NASDAQ: NBTX) Nanobiotix Sa's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 4.77%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 15.48%.

Nanobiotix Sa's earnings in 2025 is -$60,756,470.On average, 2 Wall Street analysts forecast NBTX's earnings for 2025 to be -$21,465,319, with the lowest NBTX earnings forecast at -$26,530,169, and the highest NBTX earnings forecast at -$16,400,468. On average, 2 Wall Street analysts forecast NBTX's earnings for 2026 to be $59,572,289, with the lowest NBTX earnings forecast at $2,894,200, and the highest NBTX earnings forecast at $116,250,377.

In 2027, NBTX is forecast to generate -$11,094,434 in earnings, with the lowest earnings forecast at -$11,094,434 and the highest earnings forecast at -$11,094,434.

If you're new to stock investing, here's how to buy Nanobiotix Sa stock.

What is NBTX's revenue growth forecast for 2025-2027?

(NASDAQ: NBTX) Nanobiotix Sa's forecast annual revenue growth rate of 144.61% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 87.42%, and it is also forecast to beat the US market's average forecast revenue growth rate of 11.67%.

Nanobiotix Sa's revenue in 2025 is $11,950,588.On average, 2 Wall Street analysts forecast NBTX's revenue for 2025 to be $2,370,350,013, with the lowest NBTX revenue forecast at $1,683,942,185, and the highest NBTX revenue forecast at $3,056,757,841. On average, 2 Wall Street analysts forecast NBTX's revenue for 2026 to be $9,258,787,815, with the lowest NBTX revenue forecast at $8,651,246,944, and the highest NBTX revenue forecast at $9,866,328,686.

In 2027, NBTX is forecast to generate $5,352,823,381 in revenue, with the lowest revenue forecast at $5,352,823,381 and the highest revenue forecast at $5,352,823,381.

What is NBTX's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: NBTX) forecast ROA is 68.07%, which is higher than the forecast US Biotechnology industry average of 36.87%.

What is NBTX's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: NBTX) Nanobiotix Sa's current Earnings Per Share (EPS) is -$1.28. On average, analysts forecast that NBTX's EPS will be -$0.45 for 2025, with the lowest EPS forecast at -$0.55, and the highest EPS forecast at -$0.34. On average, analysts forecast that NBTX's EPS will be $1.24 for 2026, with the lowest EPS forecast at $0.06, and the highest EPS forecast at $2.41. In 2027, NBTX's EPS is forecast to hit -$0.23 (min: -$0.23, max: -$0.23).

What is NBTX's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: NBTX) forecast ROE is -44.6%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.